Role of Microenvironmental-Derived AXII in Myeloma Bone Disease An Exploratory Model
Study on Bone Health in Multiple Myeloma Patients
Brief description of study.
Detailed description of study
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Myeloma Bone Disease,Multiple Myeloma,Myeloma,Cancer,Oncology
-
Age: 18 years - 65 years
-
Gender: Male
Diagnosed with multiple myeloma
Exclusion Criteria
Currently pregnant or breastfeeding
Have a history of bleeding conditions
This study investigates whether substances that lead to bone destruction are present in higher amounts in the blood or bone marrow of patients with multiple myeloma. Multiple myeloma is a type of cancer that affects plasma cells, a kind of white blood cell found in bone marrow.
Participants in this study will have their blood or bone marrow tested to measure the levels of these substances. This involves collecting samples to analyze the presence of bone destructive substances.
- Who can participate: Adults with multiple myeloma can join. Participants should not be pregnant, breastfeeding, or have bleeding conditions.
- Study details: Participants will have blood or bone marrow tests to measure certain substances.
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or